16 June 2025 How to include underrepresented patients into cardiovascular clinical trials Presented at PVRI's Drug Discovery & Development Symposium 2025, by Cati Brown-Johnson, Stanford University School of Medicine Members Only Member content Register Or Login to view
16 June 2025 Addressing sex differences in treatment decisions and drug development Presented at PVRI's Drug Discovery & Development Symposium 2025, by Deimante Hoppenot, Lithuanian University of Health Sciences Members Only Member content Register Or Login to view
16 June 2025 The role of imaging in establishing disease modifying effects of a trial drug Presented at PVRI's Drug Discovery & Development Symposium 2025, by Sudarshan Rajagopal, Duke University School of Medicine Members Only Member content Register Or Login to view
16 June 2025 How to define or prove disease modification Presented at PVRI's Drug Discovery & Development Symposium 2025, by Mark Toshner, University of Cambridge Members Only Member content Register Or Login to view
16 June 2025 Implications of a new background therapy for drug development Presented at PVRI's Drug Discovery & Development Symposium 2025, by Marion Delcroix, UZ Leuven Members Only Member content Register Or Login to view
16 June 2025 How Sotatercept will change the treatment algorithm Presented at PVRI's Drug Discovery & Development Symposium 2025, by Luke Howard, Imperial College London PVRI 2025 DDDS
